The NTI CKMM test examines the amounts of creatine kinase MM isoform in the blood. Creatine kinase (CK) is an enzyme found in skeletal muscle, the brain, and the heart. It is important in energy metabolism because it catalyzes the transfer of a phosphate group from creatine phosphate to adenosine diphosphate (ADP), which results in the formation of adenosine triphosphate (ATP).
There are several isoforms of CK, with CK-MM being the most common in skeletal muscle. Because it is released into the bloodstream when muscle cells are injured, elevated levels of CK-MM in the blood can suggest muscle damage or injury.
The NTI CKMM test is used to detect and track muscle damage disorders such as muscle trauma, muscular dystrophy, rhabdomyolysis, and inflammatory myopathies. Healthcare experts can determine the extent of muscle injury and track the progression of the condition by detecting CK-MM levels.
The NTI CKMM test is normally done on a blood sample, and the results are usually reported as CK-MM activity or concentration. It is a useful tool in clinical settings for assisting with the identification and treatment of muscle-related illnesses.
Anti-CKMM antibodies are antibodies that specifically target and bind to the CKMM isoform of creatine kinase (creatine kinase muscle-type). CKMM is an enzyme found primarily in skeletal muscle tissue that catalyzes the conversion of creatine and ATP into phosphocreatine and ADP, a reaction required for muscle cells to provide energy during physical activity. Anti-CKMM antibodies have been used in a variety of applications, including muscle damage and injury diagnostic tests. When muscle tissue is damaged or injured, CKMM is released into the bloodstream, where anti-CKMM antibodies can detect it. Elevated CKMM levels in the blood are frequently indicative of muscle damage or injury, and can be used to diagnose conditions like muscular dystrophy, rhabdomyolysis, and other muscle-related disorders. Anti-CKMM antibodies have been studied for their potential therapeutic applications in addition to their diagnostic applications. Creatine kinase has been shown to play a role in a variety of physiological processes other than muscle function, such as immune system regulation and brain function. Modulating CKMM activity with anti-CKMM antibodies may thus have therapeutic benefits for a wide range of conditions, including neurodegenerative diseases and autoimmune disorders.
Product Categories
Explore
Get In Touch
- Horizon Flora, Office No. 2A & 2B First Floor, Ghodbunder Road, Bhayandarpada, Thane, Mumbai – 400615
- +91 9158047802
- support@biolaxienzymes.com